GeoPark $550 million notes offering and concurrent cash tender offer
We advised GeoPark on its high-yield notes offering and concurrent tender offer
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Maze Therapeutics $140 million IPO
The shares are listed on Nasdaq
JPMorgan Chase €2 billion notes offering
We advised JPMorgan Chase on the euro notes offering
Kioxia Holdings ¥120.4 billion IPO
The shares are listed on the Tokyo Stock Exchange
Bacardi $1 billion notes offering
The investment-grade notes are due 2030 and 2035
Sanrio ¥135.1 billion secondary offering
The shares are listed on the Tokyo Stock Exchange
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Province of Saskatchewan $1 billion global bond offering
The investment-grade debt is due 2030
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S. listing
PAR Technology $115 million convertible senior notes offering
The notes are due 2030